New Study Suggests Enzyme Blockade Could Reverse Alzheimer's
Originally Published 1 year ago — by SILive.com
A study published in Nature Neuroscience has identified the enzyme tyrosine kinase 2 (TYK2) as a potential target for treating Alzheimer's disease. In genetically modified mice with excessive tau protein, blocking TYK2 reduced harmful tau buildup and showed signs of neuronal recovery. This discovery could lead to new drug development, although further research is needed to confirm these findings in humans.